The outbreak of the new coronavirus in 2020 has touched the hearts of people all over China and even the world! According to official statistics, as of 16:00 on February 3, there were 17,335 confirmed cases nationwide and 21,558 suspected cases. The entire map of China has turned red, with Hubei, Hunan, Guangdong, Zhejiang, and Henan becoming the hardest-hit areas! This epidemic has directly affected the tourism, catering, film and television industries, and cross-border e-commerce sellers have also been deeply affected. The most direct thing is that many sellers have reported that the product return rate has increased significantly recently, and the reason for the return is not product quality issues, but foreign buyers are worried that products from China carry viruses and will cause indirect infection! However, with the instigation of foreign media, many foreign buyers are still in panic. In response, the World Health Organization has publicly stated that goods shipped from China to overseas will not carry the virus.
This statement from the World Health Organization can be regarded as a shot in the arm for the majority of cross-border e-commerce sellers. However, it is only temporary at present. If China does not win this battle as soon as possible, once it is determined by the WHO as an "epidemic country", the consequences will be very serious! Therefore, only by developing drugs to treat the new coronavirus as soon as possible can we win this battle completely! In the past two days, a piece of news has been circulating in the circle of friends, saying that a mysterious American pharmaceutical company Gilead has a drug called "Remdesivir", which has been found to be effective against the new coronavirus, and the U.S. Department of Public Safety and Health has exempted China from the patent of the drug with the approval of President Trump, allowing China to directly imitate the drug. However, on the 3rd, a Global Times reporter learned from Gilead China's Medical Information Department that the drug is under development and has not yet been launched on the market, and that the drug has not been approved to treat any disease in China or other regions. At 15:00 on February 3, the National Health Commission held a press conference. Song Shuli, spokesperson of the National Health Commission, stated that many medical institutions are organizing clinical trials on remdesivir and studying the safety and effectiveness of the drug. It is understood that remdesivir (GS-5734) is a nucleoside analogue with antiviral activity. At a certain concentration, it can inhibit the activity of SARS and MERS viruses. It has also been used in clinical trials for Ebola virus. Currently, this reagent is only used for scientific research and is not sold to ordinary patients. The price of each 100 mg is 39,500 yuan. According to an official statement from Gilead, it is currently cooperating with Chinese health authorities to conduct a randomized, controlled trial to determine whether the use of remdesivir to treat 2019-nCoV infected people is safe and effective. Gilead is also accelerating the use of 2019-nCoV virus samples for appropriate laboratory testing of remdesivir. Xiaozhi also sincerely hopes that this cooperation between China and the United States can bring hope to the fight against the epidemic. Yesterday, at around 2 p.m. on February 2, Thailand's Deputy Prime Minister and Minister of Health Anutin organized a press conference, announcing that a team of doctors from Bangkok's Rajavithi Hospital had discovered a prescription for treating COVID-19, and the treatment effect was very obvious. According to doctors at Rajavithi Hospital, a Chinese man in his 70s from Wuhan was diagnosed with COVID-19. After taking these two drugs, his condition improved significantly within half a day, and the COVID-19 test result on the next day ( within 48 hours ) turned negative. It is understood that this prescription is composed of two drugs, namely anti-AIDS drugs and anti-influenza drugs (Oseltamivir). Recent clinical use has found that it is very effective. Previously, China proposed that anti-AIDS drugs would have a therapeutic effect on early COVID-19 patients, but they were not used together with anti-influenza drugs at that time. Thai hospitals creatively combined the two drugs for the treatment of COVID-19 and found that the clinical effect was significant, which is super good news! So far, Thailand has found 19 confirmed cases of COVID-19, of which 8 have recovered and been discharged from hospital, and the remaining 11 are still in isolation and treatment. Although the treatment effect has yet to be verified, the cure rate shows that the drug is very effective. If the follow-up treatment is effective, it will really save everyone from danger! However, no specific drug for the virus has been developed yet, and the truly effective antiviral method is Don't go out !!! If you really have to go out, in addition to wearing a mask, it is best to wear gloves as well! The new coronavirus was found on the door handle of a confirmed patient's home in Guangzhou! According to the chief disinfection expert of the Chinese Center for Disease Control and Prevention, elevator buttons and door handles are frequently touched by people, so they are prone to germs. In this regard, people can prevent them by increasing the number of disinfections, separating them with tissues before touching them, or disinfecting their hands with hand disinfectant after touching them. (Source: Cross-border Black Technology) |
Cross-border experts are a professional cross-bord...
Meisheng Logistics focuses on customized services ...
Normal, once there is data abnormality, such as s...
Recently, multiple Amazon sites have launched majo...
▶ Get permanent free benefits at the end of the ar...
It is learned that Amazon founder Jeff Bezos will ...
QOOOK is the largest comprehensive cross-border e-...
The recently popular series of short videos "...
Negative keywords (negative words) are an advertis...
It is learned that according to foreign media repo...
Sino-German Venture Capital (Shenzhen Sino-German ...
Baofu Network Technology (Shanghai) Co., Ltd. was ...
RetailMeNot is a corporate service company that ma...
Since Amazon introduced the policy that requires ...
It is learned that Google recently announced the l...